Current:Home > StocksCalifornia is joining with a New Jersey company to buy a generic opioid overdose reversal drug -MarketLink
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
View
Date:2025-04-17 23:25:20
SACRAMENTO, Calif. (AP) — California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the drug that can save someone’s life during an opioid overdose, under a deal announced Monday by Democratic Gov. Gavin Newsom.
Amneal Pharmaceuticals will sell naloxone to California for $24 per pack, or about 40% cheaper than the market rate. California will give away the packs for free to first responders, universities and community organizations through the state’s Naloxone Distribution Project.
The deal is significant because it means California will be able to buy a lot more naloxone — 3.2 million packs in one year instead of 2 million — for the same total cost.
The deal means naloxone eventually will be available under the CalRx label. Newsom first proposed CalRx back in 2019 as an attempt to force drug companies to lower their prices by offering much cheaper, competing versions of life-saving medication. He signed a law in 2020 giving the authority to the state.
California governments and businesses will be able to purchase naloxone outside of the Naloxone Distribution Project, the Newsom administration said, adding the state is working on a plan to make it available for sale to individuals.
“California is disrupting the drug industry with CalRx — securing life-saving drugs at lower and transparent prices,” Newsom said in an statement provided by his office.
Naloxone has been available in the U.S. without a prescription since March of 2023, when the U.S. Food and Drug Administration approved Narcan, a nasal spray brand produced by the Maryland-based pharmaceutical company Emergent BioSolutions.
Amneal Pharmaceuticals makes a generic equivalent to Narcan that won FDA approval last week.
The naloxone packs purchased by California initially will be available under the Amneal label. The naloxone will move to the CalRx label once its approved by the U.S. Food and Drug Administration, a process the Newsom administration said could take several months.
Opioid overdose deaths, which are caused by heroin, fentanyl and oxycodone, have increased dramatically in California and across the country. Annual opioid overdose deaths in California more than doubled since 2019, reaching 7,385 deaths at the end of 2022.
California began giving away naloxone kits for free in 2018. State officials say the Naloxone Distribution Project has given out 4.1 million kits, which have reversed a reported 260,000 opioid overdoses. The money has come from taxpayers and portions of a nationwide settlement agreement with some other pharmaceutical companies.
Last year, California lawmakers agreed to spend $30 million to partner with a drug company to make its own version of naloxone. But they ended up not needing to spend that money on this deal, since Amneal Pharmaceutical was already so far along in the FDA approval process it did not require up-front funding from the state.
Instead, California will use a portion of the revenue it receives from a national opioid settlement to purchase the drugs.
Naloxone is just one drug the Newsom administration is targeting.
Last year, California signed a 10-year agreement with the nonprofit Civica to produce CalRx branded insulin, which is used to treat diabetes. California has set aside $100 million for that project, with $50 million to develop the drugs and the rest set aside to invest in a manufacturing facility. Newsom said a 10 milliliter vial of state-branded insulin would sell for $30.
Civica has been meeting with the FDA and “has a clear path forward,” the Newsom administration said.
veryGood! (3435)
Related
- DoorDash steps up driver ID checks after traffic safety complaints
- Why USC quarterback Caleb Williams isn't throwing at NFL scouting combine this week
- 3 dividend stocks that yield more than double the S&P 500
- Evers again asks Wisconsin Republicans to release $125M to combat forever chemicals pollution
- Elon Musk's skyrocketing net worth: He's the first person with over $400 billion
- Cameo is being used for political propaganda — by tricking the stars involved
- How do you get lice? Here's who is most susceptible, and the truth about how it spreads
- What is the best way to handle bullying at work? Ask HR
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Hi Hi!
- Will there be a government shutdown? Lawmakers see path forward after meeting with Biden
Ranking
- 2025 'Doomsday Clock': This is how close we are to self
- See Vanderpump Rules' Jax and Brittany Go From SUR to Suburbia in The Valley Trailer
- 3 dividend stocks that yield more than double the S&P 500
- Healthiest yogurt to choose: How much protein is in Greek, Icelandic, regular yogurt?
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Hi Hi!
- A work stoppage to support a mechanic who found a noose is snarling school bus service in St. Louis
- President Joe Biden makes surprise appearance on 'Late Night with Seth Meyers' for show's 10th anniversary
- Moon landing goes sideways: Odysseus mission will be cut short after craft tipped over
Recommendation
The White House is cracking down on overdraft fees
US Army is slashing thousands of jobs in major revamp to prepare for future wars
Bobby Berk's Queer Eye Replacement Revealed
Could Missouri’s ‘stand your ground’ law apply to the Super Bowl celebration shooters?
South Korea's acting president moves to reassure allies, calm markets after Yoon impeachment
Alec Baldwin's 'Rust' trial on involuntary manslaughter charge set for July
Federal judge reverses himself, rules that California’s ban on billy clubs is unconstitutional
SAG-AFTRA adjusts intimacy coordinator confidentiality rules after Jenna Ortega movie